These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14492657)

  • 1. Symposium on clinical drug evaluation and human pharmacology. XVIII. Data management.
    ROACH CJ
    Clin Pharmacol Ther; 1962; 3():682-4. PubMed ID: 14492657
    [No Abstract]   [Full Text] [Related]  

  • 2. Symposium on clinical drug evaluation and human pharmacology. XVII. Physicochemical and pharmaceutic properties of drugs that influence the results of clinical trials.
    NELSON E
    Clin Pharmacol Ther; 1962; 3():673-81. PubMed ID: 14478906
    [No Abstract]   [Full Text] [Related]  

  • 3. Symposium on clinical drug evaluation and human pharmacology. XVI. Evaluation of the safety of new drugs by means of tests in animals.
    LITCHFIELD JT
    Clin Pharmacol Ther; 1962; 3():665-72. PubMed ID: 14465857
    [No Abstract]   [Full Text] [Related]  

  • 4. Some fallacies and errors in the application of the principle of consent in human experimentation.
    BEECHER HK
    Clin Pharmacol Ther; 1962; 3():141-6. PubMed ID: 13866499
    [No Abstract]   [Full Text] [Related]  

  • 5. Symposium on clinical drug evaluation and human pharmacology. Introduction. Clinical pharmacology: a definition.
    MODELL W
    Clin Pharmacol Ther; 1962; 3():235-8. PubMed ID: 14474954
    [No Abstract]   [Full Text] [Related]  

  • 6. Promoting Patient Interests in Implementing the Federal Right to Try Act.
    Lynch HF; Zettler PJ; Sarpatwari A
    JAMA; 2018 Sep; 320(9):869-870. PubMed ID: 30105394
    [No Abstract]   [Full Text] [Related]  

  • 7. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
    Schultheis LW; Rappaport BA
    Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
    [No Abstract]   [Full Text] [Related]  

  • 8. Symposium on clinical drug evaluation and human pharmacology. IV. Placebos: problems and pitfalls.
    WOLF S
    Clin Pharmacol Ther; 1962; 3():254-7. PubMed ID: 14007964
    [No Abstract]   [Full Text] [Related]  

  • 9. Symposium on clinical drug evaluation and human pharmacology. III. A modification of the standard sequential test for the relative effectiveness of two therapies.
    STREET E
    Clin Pharmacol Ther; 1962; 3():246-53. PubMed ID: 13917729
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacoeconomic analyses--chance or 4th hurdle for innovative drugs].
    Krammer H
    Wien Med Wochenschr; 2006 Dec; 156(23-24):606-11. PubMed ID: 17211764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is a truly innovative drug? New definition from the International Society of Drug Bulletins.
    Kopp C
    Can Fam Physician; 2002 Sep; 48():1413-5, 1424-6. PubMed ID: 12371294
    [No Abstract]   [Full Text] [Related]  

  • 12. Access for the terminally ill to experimental medical innovations: a three-pronged threat.
    Bender S; Flicker L; Rhodes R
    Am J Bioeth; 2007 Oct; 7(10):3-6. PubMed ID: 17926208
    [No Abstract]   [Full Text] [Related]  

  • 13. When I use a word ... Innovations--'The Births of Time'.
    Aronson JK
    QJM; 2012 Oct; 105(10):1037-9. PubMed ID: 22690008
    [No Abstract]   [Full Text] [Related]  

  • 14. [Closed-loop management model of clinical investigational product for new drug of traditional Chinese medicine].
    Wu P; Zhang JW
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(17):2898-900. PubMed ID: 24380320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Innovative drugs for the good of the patients].
    Dietrich W
    Krankenpfl J; 2005; 43(4-6):136. PubMed ID: 16171078
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Pharmacology of Antimalarial Drugs--First AHRO International Malaria Symposium.
    Kurtzhals J
    IDrugs; 2008 Oct; 11(10):713-5. PubMed ID: 18828068
    [No Abstract]   [Full Text] [Related]  

  • 17. Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic Use.
    Nayak S; Sander O; Al-Huniti N; de Alwis D; Chain A; Chenel M; Sunkaraneni S; Agrawal S; Gupta N; Visser SAG
    Clin Pharmacol Ther; 2018 Mar; 103(3):378-383. PubMed ID: 29330855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drugs and the market].
    Tognoni G
    Assist Inferm Ric; 2008; 27(4):226-9. PubMed ID: 19260373
    [No Abstract]   [Full Text] [Related]  

  • 20. US Food and Drug Administration Efforts to Facilitate the Use of Expanded Access Programs.
    Kim T; Lurie P; Pazdur R
    J Clin Oncol; 2015 Nov; 33(33):3979-80. PubMed ID: 26282656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.